Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment
Completed · Phase 2
Conditions studied: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia
In brief
The primary objective of this study is to evaluate the safety of zanubrutinib (also known as BGB-3111) in chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenström macroglobulinemia, mantle cell lymphoma, or marginal zone lymphoma patients who have become intolerant of prior ibrutinib and/or acalabrutinib treatment, by comparing intolerance to adverse event profile as assessed by the recurrence and the change in severity of adverse events.
Key facts
- Study ID
- NCT04116437
- Run by
- BeiGene
- People needed
- 96
- Starts
- 2019-10-15
- Expected to finish
- 2026-01-09
- Last updated by the study team
- 2026-01-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Rocky Mountain Cancer Centers (Williams) Usor — Aurora, Colorado, United States
- Christiana Care — Newark, Delaware, United States
- Scri Florida Cancer Specialists South — Fort Myers, Florida, United States
- St Century Oncology — Jacksonville, Florida, United States
- Scri Florida Cancer Specialists North — St. Petersburg, Florida, United States
- Healthcare Research Network Iii, Llc — Flossmoor, Illinois, United States
- Minnesota Oncology Burnsville Clinic — Burnsville, Minnesota, United States
- Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada, United States
- Summit Medical Group — Florham Park, New Jersey, United States
- Morristown Medical Center — Morristown, New Jersey, United States
- Clinical Research Alliance, Inc — Westbury, New York, United States
- Oncology Associates of Oregon Willamette Valley Cancer Center — Eugene, Oregon, United States
- St Lukes University Health Network — Fountain Hill, Pennsylvania, United States
- Abington Hematology Oncology Associates — Horsham, Pennsylvania, United States
- Tennessee Oncology, Pllc Nashville — Nashville, Tennessee, United States
- Texas Oncology Amarillo — Amarillo, Texas, United States
- Texas Oncology Tyler Longview — Austin, Texas, United States
- Baylor Research Institute — Dallas, Texas, United States
- Texas Oncology McAllen South Second Street — McAllen, Texas, United States
- Us Oncology Virginia Cancer Specialists, Pc — Fairfax, Virginia, United States
- Virginia Oncology Associates — Norfolk, Virginia, United States
- Fred Hutchinson Cancer Research Center — Seattle, Washington, United States
- Medical Oncology Associates — Spokane, Washington, United States
- Ssm Health Cancer Care Dean Medical Center — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.